Tech Company Financing Transactions
RetiSpec Funding Round
RetiSpec, operating out of Toronto, ON, secured $10 million from iGan Partners, Alzheimer's Drug Discovery Foundation and CABHI.
Transaction Overview
Company Name
Announced On
7/26/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
170 Bedford Rd
Toronto, ON, M5R 2K9
Canada
Toronto, ON, M5R 2K9
Canada
Phone
Undisclosed
Website
Email Address
Overview
At RetiSpec, we believe a better future for Alzheimer's starts with the ability to diagnose it. Our mission is to enable widespread early and accurate detection of neurodegenerative disease markers with accessible, affordable and scalable AI-driven retinal imaging. To achieve this vision, we are developing a point of care and AI-driven early detection of Alzheimer's, through a simple eye exam.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eliav Shaked
Chief Operating Officer
Roy Kirshon
Chief Technical Officer
Alon Hazan
VP - Bus. Development
Catherine Bornbaum
Browse more venture capital transactions:
Prev: 7/25/2024: ShiftRX venture capital transaction
Next: 7/26/2024: Passionfruit venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs